Oncomatryx Biopharma S.L.Antibody-Drug-ConjugateOncomatryx Secures EU Funding to Advance Antibody-Drug Conjugate PlatformSpanish biotechnology company Oncomatryx Biopharma has been selected for funding under the European Innovation Council (EIC) Accelerator, part of the EU’s Horizon Europe 2021–2027 Research and Innovation … more ➔
David_SMC from PixabayAcquisitionVerona Pharma: A Transatlantic Success Story in the Biotech LandscapeThe planned US$10 billion acquisition of UK-based Verona Pharma by US pharmaceutical giant Merck & Co. underscores several key dynamics reshaping the global biotech industry. Not only does the deal reflect … more ➔
AmphiStar BVBio-basedAmphiStar: €12.5m EIC Funding to Advance Commercialisation of Bio-Based SurfactantsThe new funding includes €2.5m grant and €10m equity investment and supports Belgian AmphiStar’s potential to reshape the surfactants market. This investment will accelerate scale-up and market … more ➔
Cyril MarcilhacyCellular AgricultureUK Food Standards Agency accepts Gourmey’s application for cultivated Foie GrasThe British Food Standards Agency (FSA) has formally accepted an application by French start-up Gourmey SAS for regulatory approval of its cultivated foie gras, a product developed using cellular agriculture … more ➔
Rheticus/EvonikCarbon captureFirst step towards scaling chemical production from CO₂As part of the green transformation of North Rhine-Westphalia’s former coal-mining region, independent assessors have recommended the co-financing of two biotechnology processes developed at pilot … more ➔
Nuclidium AGRadiopharmaceuticalsNuclidium fuels next radiopharma waveBasel-based NUCLIDIUM AG has successfully closed a Series B financing round of CHF 79 million (EUR 84 million) to advance the development of its copper-based radiopharmaceutical platform. The round was … more ➔
Actithera Norway ASRadiopharmaceuticalsActithera: Radiopharma Funding Gathers Huge MomentumThe biotech company Actithera, with locations in Cambridge, USA, and Oslo, Norway, has successfully closed a major Series A round, raising US $75.5 million. Its isotope-agnostic platform — designed … more ➔
adobe stock photos - Wang Dan AdipositasCiloa SAS secures €6.5m to advance lead candidate APN-sEV into clinical developmentFrench biotech Ciloa SAS has received a €6.5m grant to advance its adiponectin-loaded exosome candidate, APN-sEV, into Phase I safety trials, ahead of efficacy evaluation in indications including type … more ➔
Solar FoodsFood BiotechnologySolar Foods continues expansion in the USAfter Finnish protein powder producer Solarfoods signed a strategic agreement with two US food manufacturers to supply 6,000 tonnes of Solein from 2030 onwards, the company has now announced a more concrete … more ➔
ECEuropean CommissionEuropean Commission to fund Life Sciences Strategy using Cohesion Fund resourcesThe European Commission last week unveiled its Life Sciences Strategy, which aims to elevate Europe’s biotechnology sector from third to first place globally by 2030, backed by an investment of €10bn. … more ➔
Oncomatryx Biopharma S.L.
David_SMC from Pixabay
AmphiStar BV
Cyril Marcilhacy
Rheticus/Evonik
Nuclidium AG
Actithera Norway AS
adobe stock photos - Wang Dan 
Solar Foods
EC